APA način citiranja

Shao, L., Kahraman, N., Yan, G., Wang, J., Ozpolat, B., & Ittmann, M. (2019). Targeting the TMPRSS2/ERG fusion mRNA using liposomal nanovectors enhances docetaxel treatment in prostate cancer. Prostate.

Čikaški stil citiranja

Shao, Longjiang, Nermin Kahraman, Ge Yan, Jianghua Wang, Bulent Ozpolat, i Michael Ittmann. "Targeting the TMPRSS2/ERG Fusion MRNA Using Liposomal Nanovectors Enhances Docetaxel Treatment in Prostate Cancer." Prostate 2019.

MLA način citiranja

Shao, Longjiang, et al. "Targeting the TMPRSS2/ERG Fusion MRNA Using Liposomal Nanovectors Enhances Docetaxel Treatment in Prostate Cancer." Prostate 2019.